Vera Therapeutics Inc.

VERA | NASDAQ

Price Alert Chart Builder DCF Calculator

$34.25

+$0.25 (+0.74%)

At close: Sep 21, 2026, 4:00 PM ET

$34.64

+$0.39 (+1.14%)

Pre-market: Sep 22, 2026, 9:11 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.46B

Enterprise Value $2.03B

Beta 0.95

Average Volume 1.81M

Shares Outstanding (Diluted) 71.84M

Shares Change YoY 12.62%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US92337R1014

Price Performance

Price Change 1M 6.2%

Price Change 3M -10.3%

Price Change 6M -14.7%

Price Change YTD -29.6%

Price Change 1Y 31.2%

Price Change 3Y 135.9%

Price Change 5Y 103.9%

1M CAGR (ann.) 4.1%

1Y CAGR (ann.) 30.0%

5Y CAGR (ann.) 5.3%

All-Time CAGR 22.6%

Valuation

PE Ratio -5.84

Forward PE N/A

PEG Ratio 0.14

Forward PEG 0.20

PS Ratio N/A

Forward PS 11.10

PB Ratio 6.03

P/FCF Ratio -7.25

P/Adj. FCF Ratio -6.32

P/OCF Ratio -7.27

EV/Sales N/A

EV/EBIT -5.21

EV/EBITDA -5.22

EV/FCF -6.00

Earnings Yield -17.1%

FCF Yield -13.8%

Adj. FCF Yield -15.8%

Financial Health

Net Cash $423.93M

Total Debt $75.23M

Cash & Short-Term Investments $499.16M

Total Assets $532.98M

Current Ratio 10.92

Quick Ratio 10.92

Debt / Equity Ratio 0.18

Debt / EBITDA -0.19

Debt / FCF -0.22

OCF / Debt -4.50

Interest Coverage -36.93

Altman Z-Score 7.84

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -14.7%

Returns

Return on Assets -75.4%

Return on Equity -84.1%

Return on Invested Capital -85.8%

Return on Capital Employed -85.8%

Return on Tangible Assets -75.4%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -46.5%

EPS CAGR 5Y -20.9%

EPS CAGR 10Y N/A

FCF CAGR 3Y -53.0%

FCF CAGR 5Y -46.5%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 14

EPS Growth Next 3Y 49.8%

Revenue Growth Next 3Y N/A

Earnings Date Nov 3, 2026

EPS Estimate (next Q) -$1.62

EPS Growth Est (next Q) 28.3%

Revenue Est (next Q) $4.28M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $86.75

Price Target Upside 153.3%

Cash Flow

Operating Cash Flow $-338.65M

Free Cash Flow $-339.06M

Adj. Free Cash Flow $-388.84M

FCF Per Share -$4.72

OCF Per Share -$4.71

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $871K

Operating Income $-415.76M

EBITDA $-389.99M

Net Income $-401.9M

EPS (Diluted) -$5.86

Revenue / Employee N/A

Profit / Employee $-1.11M

Employees 361